Assembly Biosciences
ASMB
22 hedge funds and large institutions have $14.1M invested in Assembly Biosciences in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
58% more capital invested
Capital invested by funds: $8.97M → $14.1M (+$5.16M)
19% less funds holding
Funds holding: 27 → 22 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$665K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$611K |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$370K |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$185K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$161K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$123K |
| 2 |
D.E. Shaw & Co
New York
|
-$59K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$43K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42K |
| 5 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NCCM
26
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$37K | -477 | Closed |
|
27
Citadel Advisors
Miami,
Florida
| – | -$18K | -234 | Closed |
|
28
Bank of New York Mellon
New York
| – | -$16K | -208 | Closed |
|
|
BA
29
BlackRock Advisors
Wilmington,
Delaware
| – | -$9K | -115 | Closed |
|
30
BNP Paribas Financial Markets
Paris,
France
| – | -$1.55K | -20 | Closed |
|
ASMB Hedge Fund Activity: Q3 2014 in Review
22 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2014, worth a combined $14.1M — up 58% from $8.97M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ASMB and 5 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Visium Asset Management, adding an estimated $665K. The largest seller was Jane Street, exiting entirely with an estimated $123K sold.
- 22 institutional investors held Assembly Biosciences (ASMB) as of Q3 2014, down from 27 in Q2 2014.
- Funds reported $14.1M of Assembly Biosciences stock for Q3 2014, up 58% quarter-over-quarter.
- 5 funds opened new Assembly Biosciences positions in Q3 2014 and 10 closed out, a net change of -5 holders.
- The largest Assembly Biosciences buyer in Q3 2014 was Visium Asset Management, an estimated $665K added.
- The largest Assembly Biosciences seller in Q3 2014 was Jane Street, an estimated $123K sold.
Based on aggregated 13F filings for Q3 2014.